Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares
FLAC
FLAC was delisted on the 22nd of November, 2022.
42 hedge funds and large institutions have $69.5M invested in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
43% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 7
9% more capital invested
Capital invested by funds: $63.6M → $69.5M (+$5.93M)
2% more funds holding
Funds holding: 41 → 42 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
+$3.78M |
| 2 |
Millennium Management
New York
|
+$2.13M |
| 3 |
BCM
Bluefin Capital Management
New York
|
+$661K |
| 4 |
D.E. Shaw & Co
New York
|
+$446K |
| 5 |
FTCM
First Trust Capital Management
Chicago,
Illinois
|
+$335K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$1.27M |
| 2 |
CIBC World Market
Toronto,
Ontario, Canada
|
-$503K |
| 3 |
CC
Centiva Capital
New York
|
-$281K |
| 4 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$88.9K |
| 5 |
GCM
Ghisallo Capital Management
Boston,
Massachusetts
|
-$34.2K |
FLAC Hedge Fund Activity: Q3 2021 in Review
42 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) for Q3 2021, worth a combined $69.5M — up 9.3% from $63.6M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new FLAC positions and 2 closed out — a net gain of 1 holder — while 10 added to existing stakes and 7 trimmed.
The largest buyer was EcoR1 Capital, adding an estimated $3.78M. The largest seller was Hudson Bay Capital Management, cutting an estimated $1.27M.
- 42 institutional investors held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) as of Q3 2021, up from 41 in Q2 2021.
- Funds reported $69.5M of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares stock for Q3 2021, up 9.3% quarter-over-quarter.
- 3 funds opened new Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares positions in Q3 2021 and 2 closed out, a net change of +1 holder.
- The largest Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares buyer in Q3 2021 was EcoR1 Capital, an estimated $3.78M added.
- The largest Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares seller in Q3 2021 was Hudson Bay Capital Management, an estimated $1.27M sold.
Based on aggregated 13F filings for Q3 2021.